Daily Brief - April 01, 2026 (EOD)

 ## Market Recap The major U.S. indices closed higher on the day, led by the Nasdaq 100 which gained 1.11%, closing at $583.60. The S&P 500 followed with a solid 0.64% advance to $654.50, while the Dow Jones Industrial Average rose 0.49% to $465.45. The Russell 2000 also posted gains, up 0.58% to $249.44, signaling broad-based strength including small caps. The session featured steady volume, with the S&P 500 ETF (SPY) trading 97.9 million shares and the Nasdaq 100 ETF (QQQ) seeing 79.7 million shares, reflecting healthy investor participation. Market sentiment was buoyed by optimism around geopolitical developments, particularly expectations of a near-term de-escalation in the Iran conflict, which helped ease energy price pressures. Technology led the charge, supported by strong earnings and strategic moves from key chipmakers. Despite the energy sector's sharp decline amid falling oil prices, the overall market tone was constructive, with breadth favoring gains across most sectors. ## Top Stories That Moved Markets - **Intel's $14.2 Billion Fab Buyback**: Intel announced it would buy back Apollo Global Management’s 49% stake in its Ireland Fab 34 for $14.2 billion, signaling a strategic move to reclaim full control of a key AI chip manufacturing facility. This boosted **$INTC** shares by 8.91%, reflecting renewed investor confidence in Intel's AI ambitions and manufacturing strength. - **Boeing and Lockheed Martin to Triple Missile Output**: The Pentagon's decision to ramp up production of PAC-3 missile seekers with Boeing and Lockheed Martin contracts lifted defense stocks, with **$BA** surging 4.17% on the news. This move underscores increased defense spending amid geopolitical tensions. - **Eli Lilly FDA Approval for Oral Obesity Pill**: Eli Lilly received FDA approval for its GLP-1 oral obesity drug, driving a 3.78% gain in **$LLY** shares. The approval marks a significant milestone in the weight-loss drug market, enhancing Lilly’s growth outlook. - **Nike Earnings and Guidance Disappoint**: Nike reported weaker-than-expected guidance and ongoing challenges in China, causing a sharp 15.51% drop in **$NKE** shares. The miss weighed on consumer discretionary sentiment and highlighted ongoing headwinds in apparel retail. - **Energy Sector Selloff on Oil Price Drop**: Oil prices fell 2.90% to $123.56 per barrel, dragging energy stocks lower. **$XLE** declined 4.16%, with major energy companies like **$XOM** and **$CVX** falling 5.23% and 4.59%, respectively, as easing Iran war concerns reduced supply risk premiums. ## Biggest Winners - **$CYCN** +301.24% – Cyclerion Therapeutics saw a massive rally, likely driven by M&A speculation and positive clinical developments in rare disease therapeutics. - **$AGPU** +127.16% – Axe Compute surged after appointing Kyle Okamoto as president, signaling potential operational improvements and growth in GPU infrastructure contracts. - **$NBTX** +10.37% – Nanobiotix rallied on strong Q4 earnings and pipeline progress, boosting investor enthusiasm. - **$NCNO** +10.61% – nCino’s stock jumped on strong bookings and healthy free cash flow outlook, supported by an upgrade from analysts. - **$MU** +9.52% – Micron Technology gained sharply on robust AI demand and positive analyst sentiment, marking its biggest gain in a year. - **$INTC** +8.91% – Intel’s strategic fab buyback fueled a strong rally, reflecting renewed optimism in its AI chip production capabilities. - **$BHVN** +13.71% – Biohaven surged after encouraging clinical data on its migraine drug, boosting confidence in its pipeline. - **$OMER** +13.65% – Omeros Corporation rallied following positive earnings and pipeline updates. ## Biggest Losers - **$RH** -19.29% – Restoration Hardware plunged after missing earnings estimates and issuing weak Q1 guidance, reflecting concerns about the luxury home goods market. - **$TPB** -14.45% – Turning Point Brands saw a sharp selloff amid valuation concerns and sector rotation away from tobacco stocks. - **$NKE** -15.51% – Nike’s steep decline followed disappointing guidance and ongoing challenges in the Chinese market. - **$ORIC** -40.25% – ORIC Pharmaceuticals collapsed after negative updates on dose optimization and trial design, raising doubts about its prostate cancer drug prospects. - **$XBP** -11.14% – XBP Global Holdings fell sharply, likely due to sector weakness and valuation pressures. - **$CODX** -11.83% – Co-Diagnostics declined on earnings miss and revenue shortfall, weighing on sentiment. - **$KULR** -13.15% – KULR Technology dropped amid concerns over financials and sector rotation. - **$SNYR** -20.93% – Synergy CHC Corp. plunged on pipeline and valuation concerns. ## Sector Scorecard - **Leaders:** Technology (+1.42%) led all sectors, driven by strong earnings and strategic investments in AI chip production. Healthcare (+0.75%) and Consumer Discretionary (+0.75%) also outperformed, supported by positive drug approvals and selective retail strength. - **Laggards:** Energy (-4.16%) was the weakest sector, pressured by a nearly 3% drop in oil prices amid easing geopolitical tensions. Consumer Staples (-0.63%) and Real Estate (-6.74%) also lagged, reflecting profit-taking and sector-specific headwinds. ## After-Hours Movers - **$ORIC** – ORIC Pharmaceuticals shares plunged 40.25% today following disappointing clinical updates. Watch for continued volatility in after-hours trading. - **$PLAY** – Dave & Buster’s surged 19.11% after reporting strong Q4 earnings, signaling consumer spending resilience in experiential retail. - **$WDC** – Western Digital jumped 10.42% on robust AI demand and positive analyst commentary, extending gains into after-hours. - **$CYCN** – Cyclerion Therapeutics continues to rally in after-hours, up over 300% on M&A speculation and pipeline optimism. ## Crypto & Commodities - Bitcoin (BTC) edged down slightly by 0.08% to $68,176.10, holding near recent highs amid mixed risk sentiment. - Ethereum (ETH) outperformed with a 1.97% gain to $2,144.90, supported by renewed interest in smart contract platforms. - Gold (GLD) extended its rally, rising 1.91% to $438.50, benefiting from geopolitical uncertainty and safe-haven demand. - Oil (USO) declined 2.90% to $123.56 per barrel, pressured by easing Iran war concerns and expectations of increased supply. ## Tomorrow Setup Investors should focus on several key developments in the coming session: - Economic data includes the ADP National Employment report for March, which showed 62,000 new jobs versus a forecast of 40,000, indicating steady labor market conditions. The JOLTS Job Openings report for February showed a decline to 6.882 million, slightly below expectations, which may influence market expectations for future Fed policy. - Earnings momentum remains centered on technology and healthcare stocks. Watch for follow-up reactions in chipmakers like **$MU**, **$AMD**, and **$INTC** after their recent moves. Consumer discretionary names such as **$PVH** and **$PLAY** also showed strength. - Risk factors include ongoing geopolitical uncertainty around the Iran conflict and the potential for oil price volatility. Energy sector investors will monitor oil inventories and API reports released overnight. - Key upcoming earnings to watch include **$MSFT**, **$META**, and **$SNAP**, which could provide further insight into tech sector resilience amid mixed macro signals. - Market participants will also track consumer confidence and manufacturing PMI data, which have shown mixed signals recently, to gauge the sustainability of economic growth. Overall, the market appears cautiously optimistic with technology and healthcare leading gains, while energy remains under pressure. Investors should remain attentive to geopolitical developments and earnings updates that could drive volatility in the near term.